The US may have paused its trade war with China, but Beijing still holds a powerful lever: control over the inputs that go into essential medicines. As Washington mulls its options, could India become a critical partner for pharma resilience?
What happens if China weaponizes its global dominance of pharmaceutical ingredients?
📅 Published: November 27, 2025 |
📂 Category: Uncategorized
